|4May 26, 4:17 PM ET

Ryweck Daniel E. 4

4 · Silo Pharma, Inc. · Filed May 26, 2023

Insider Transaction Report

Form 4
Period: 2023-05-26
Ryweck Daniel E.
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2023-05-26$2.13/sh+1,000$2,1265,000 total

Documents

1 file
  • 4
    ownership.xmlPrimary